EVpedia 2.0

This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:

Superdomain: All Prokaryote Eukaryote

Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).

Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.

Number of molecules in one page:

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name	miRBase accession	FPR	TPR	Publication	Orthologous group	Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5)
hsa-miR-516a-3p	MIMAT0006778	0.0e+0	4.8e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517a-3p	MIMAT0002852	0.0e+0	4.9e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517b-3p	MIMAT0002857	0.0e+0	4.2e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517b-3p	MIMAT0002857	0.0e+0	2.4e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518c-3p	MIMAT0002848	0.0e+0	4.9e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518f-3p	MIMAT0002842	0.0e+0	3.2e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520d-3p	MIMAT0002856	0.0e+0	3.5e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520f-3p	MIMAT0002830	0.0e+0	1.2e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520g-3p	MIMAT0002858	0.0e+0	2.5e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-522-3p	MIMAT0002868	0.0e+0	3.3e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-523-3p	MIMAT0002840	0.0e+0	8.1e-2	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-524-3p	MIMAT0002850	0.0e+0	5.1e-2	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-524-3p	MIMAT0002850	0.0e+0	2.2e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-525-3p	MIMAT0002839	0.0e+0	4.5e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-525-3p	MIMAT0002839	0.0e+0	2.9e-1	Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518e-3p	MIMAT0002861	7.9e-8	4.9e-1	Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.	MIPF0000020_2	51 / 0 / 51
hsa-miR-522-3p	MIMAT0002868	1.8e-7	4.9e-1	Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519c-3p	MIMAT0002832	1.2e-6	4.9e-1	Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519b-3p	MIMAT0002837	2.0e-6	4.9e-1	Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.	MIPF0000020_2	51 / 0 / 51
hsa-miR-523-3p	MIMAT0002840	2.5e-6	4.9e-1	Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518f-3p	MIMAT0002842	6.1e-5	5.0e-1	Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520c-3p	MIMAT0002846	9.6e-5	5.0e-1	Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.	MIPF0000020_2	51 / 0 / 51
hsa-miR-515-3p	MIMAT0002827	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517a-3p	MIMAT0002852	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517b-3p	MIMAT0002857	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518a-3p	MIMAT0002863	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518c-3p	MIMAT0002848	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518d-3p	MIMAT0002864	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518e-3p	MIMAT0002861	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519c-3p	MIMAT0002832	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519d-3p	MIMAT0002853	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519e-3p	MIMAT0002829	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520a-3p	MIMAT0002834	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520f-3p	MIMAT0002830	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520g-3p	MIMAT0002858	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-522-3p	MIMAT0002868	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-523-3p	MIMAT0002840	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-525-3p	MIMAT0002839	1.3e-7	0.0e+0	Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519d-3p	MIMAT0002853	0.0e+0	2.8e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519d-3p	MIMAT0002853	0.0e+0	3.6e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519c-3p	MIMAT0002832	0.0e+0	1.1e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-516b-3p	MIMAT0002860	0.0e+0	2.8e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518d-3p	MIMAT0002864	0.0e+0	1.0e-2	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518f-3p	MIMAT0002842	0.0e+0	1.9e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520d-3p	MIMAT0002856	0.0e+0	4.2e-5	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-524-3p	MIMAT0002850	0.0e+0	1.2e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-525-3p	MIMAT0002839	0.0e+0	4.9e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-526b-3p	MIMAT0002836	0.0e+0	1.1e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-516b-3p	MIMAT0002860	0.0e+0	3.0e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520d-3p	MIMAT0002856	0.0e+0	4.9e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-522-3p	MIMAT0002868	0.0e+0	3.7e-1	Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518e-3p	MIMAT0002861	0.0e+0	5.0e-1	The human miRNA repertoire of different blood compounds. BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520d-3p	MIMAT0002856	0.0e+0	3.3e-1	The human miRNA repertoire of different blood compounds. BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520d-3p	MIMAT0002856	0.0e+0	3.8e-1	The human miRNA repertoire of different blood compounds. BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.	MIPF0000020_2	51 / 0 / 51
hsa-miR-515-3p	MIMAT0002827	0.0e+0	4.8e-1	MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517c-3p	MIMAT0002866	0.0e+0	4.0e-1	MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520f-3p	MIMAT0002830	0.0e+0	5.0e-1	MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520d-3p	MIMAT0002856	0.0e+0	4.8e-1	MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.	MIPF0000020_2	51 / 0 / 51
hsa-miR-515-3p	MIMAT0002827	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517a-3p	MIMAT0002852	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517c-3p	MIMAT0002866	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518a-3p	MIMAT0002863	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518c-3p	MIMAT0002848	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518e-3p	MIMAT0002861	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519c-3p	MIMAT0002832	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519d-3p	MIMAT0002853	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519e-3p	MIMAT0002829	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520a-3p	MIMAT0002834	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520f-3p	MIMAT0002830	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520g-3p	MIMAT0002858	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-522-3p	MIMAT0002868	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-525-3p	MIMAT0002839	5.5e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-515-3p	MIMAT0002827	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517b-3p	MIMAT0002857	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518a-3p	MIMAT0002863	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518c-3p	MIMAT0002848	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518d-3p	MIMAT0002864	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519c-3p	MIMAT0002832	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520a-3p	MIMAT0002834	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520f-3p	MIMAT0002830	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520g-3p	MIMAT0002858	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-522-3p	MIMAT0002868	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-523-3p	MIMAT0002840	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-525-3p	MIMAT0002839	3.8e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518a-3p	MIMAT0002863	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518c-3p	MIMAT0002848	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518d-3p	MIMAT0002864	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518e-3p	MIMAT0002861	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519c-3p	MIMAT0002832	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-519e-3p	MIMAT0002829	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520a-3p	MIMAT0002834	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520f-3p	MIMAT0002830	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-520g-3p	MIMAT0002858	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-522-3p	MIMAT0002868	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-525-3p	MIMAT0002839	9.7e-3	0.0e+0	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-515-3p	MIMAT0002827	9.3e-4	9.3e-4	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517b-3p	MIMAT0002857	9.3e-4	9.3e-4	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-517c-3p	MIMAT0002866	9.3e-4	9.3e-4	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518a-3p	MIMAT0002863	9.3e-4	9.3e-4	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51
hsa-miR-518c-3p	MIMAT0002848	9.3e-4	9.3e-4	Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014 Oct 15. pii: blood-2014-05-576116.	MIPF0000020_2	51 / 0 / 51

< [2] [3] [4]